H.I.G. BioHealth Partners

H.I.G. BioHealth Partners invests in a broad range of life science companies across multiple sectors and stages of development.

Be the first to review

Independent rating of H.I.G. BioHealth Partners VC fund

Overall rating:
Not reviewed

About H.I.G. BioHealth Partners VC fund

Website:
http://www.higbio.com
Founded:
2011
Number of funds:
1
Number of investments:
26
Number of exits:
7
Headquarters:
Miami, United States
Organization type:
Venture Capital

How H.I.G. BioHealth Partners VC fund invests

Rounds:
Series A, Venture Round, Series B, Series D, Series C
Average ticket size:
12.2M USD
Smallest investment:
1.14M USD
Biggest investment:
51.2M USD
Would lead round:
Yes
Would coinvest:
Yes
Countries where invested:
United States, Switzerland
Sectors of interest:
Biotechnology, Health Care, Therapeutics, Pharmaceutical, Medical Device, Medical, Health Diagnostics, Biopharma, Manufacturing, Life Science, Genetics

Portfolio - latest investments by H.I.G. BioHealth Partners VC fund
Neurana Pharmaceuticals
Zerigo Health
On Target Laboratories
Exagen
Arvelle Therapeutics
Click Therapeutics
Iconic Therapeutics
Intact Vascular

Founders' reviews of H.I.G. BioHealth Partners VC fund

Be the first one to review H.I.G. BioHealth Partners.
Nobody reviews H.I.G. BioHealth Partners just yet. Help other founders navigate by writing about your experience with them.
Similar funds